Physician profile
Jonathan Gross
NPI 1194920751
$743.47
in general payments reported to CMS, 2019-2025
9 companies · $48.24 in 2025
The $48.24 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.33 · 2020: $12.31 · 2021: $113 · 2022: $294 · 2023: $67.44 · 2024: $147 · 2025: $48.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $178.21 | 2022-2024 | Concertotm |
| Stryker Corporation | $164.04 | 2019-2024 | T2 Alpha, Gamma, Pangea |
| Terumo Medical Corporation | $142.87 | 2022-2025 | Azur Cx Detachable |
| Siemens Medical Solutions USA, INC. | $95.67 | 2021 | |
| Cvrx, INC. | $67.44 | 2023 | Barostim Neo System |
| Trisalus Life Sciences, INC. | $30.52 | 2025 | Trinav Infusion System |
| Inari Medical, INC. | $28.51 | 2019-2020 | |
| Biogen, INC. | $18.80 | 2022 | |
| Boston Scientific Corporation | $17.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.